scispace - formally typeset
X

Xian Liu

Researcher at Nanjing Medical University

Publications -  15
Citations -  1107

Xian Liu is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Cancer & Genetic enhancement. The author has an hindex of 11, co-authored 15 publications receiving 962 citations.

Papers
More filters
Journal ArticleDOI

Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway

TL;DR: It is found that UCA1 was aberrantly upregulated in HCC tissues and associated with TNM stage, metastasis and postoperative survival, and a novel lncRNA- miRNA-mRNA regulatory network that is U CA1-miR-216b-FGFR1-ERK signaling pathway in H CC is elucidated, which may help to lead a better understanding of the pathogenesis of HCC.
Journal ArticleDOI

The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients

TL;DR: It is shown that preoperative elevated NLR can be considered as an independent prognostic biomarker for RFS, OS and CSS, and Nomograms containing NLR provide improved accuracy for predicting clinical outcomes in surgical CRC patients under surgery resection.
Journal ArticleDOI

Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model

TL;DR: Pre-operative NLR and dNLR may serve as potential prognostic biomarkers in patients with GC who underwent surgical resection and could more accurately predict cancer-specific survival (CSS) and disease-free survival (DFS) in surgical GC patients.
Journal ArticleDOI

Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer

TL;DR: NLR could be considered as a predictive factor for patients with breast cancer, and appeared to be a negative prognostic marker in Caucasian populations.
Journal ArticleDOI

Up-regulation of 91H promotes tumor metastasis and predicts poor prognosis for patients with colorectal cancer.

TL;DR: In vitro data indicated that knockdown of 91H inhibited the proliferation, migration, and invasiveness of CRC cells, and might be regarded as a novel prognosis indicator in patients with CRC.